HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposes

Journal of Separation Science

Volumn 28, Issue 3, 2005, Pages 245-250

  Raggi, Maria Augusta ^a   Bugamelli, Francesca ^a   Sabbioni, Cesare ^a   Saracino, Maria Addolorata ^a   Petio, Carmine ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

Author keywords

9 Hydroxyrisperidone; Human plasma; Liquid chromatography; Overdose; Risperidone; Solid phase extraction

Indexed keywords

DIODES; LIQUID CHROMATOGRAPHY; METHANOL; PH; SENSITIVITY ANALYSIS;

DIODE ARRAY DETECTION; EXTRACTION YIELD; MOBILE PHASES; POLYPHARMACY;

CHEMICAL ANALYSIS;

ACETONITRILE; AMITRIPTYLINE; AMOXAPINE; BUFFER; CARBAMAZEPINE; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; CLOTIAPINE; CLOZAPINE; DESVENLAFAXINE; DRUG METABOLITE; FLUOXETINE; HALOPERIDOL; IMIPRAMINE; LAMOTRIGINE; LORAZEPAM; LOXAPINE; METHANOL; NEUROLEPTIC AGENT; OLANZAPINE; PALIPERIDONE; PAROXETINE; PHENOBARBITAL; PHOSPHATE; PRIMIDONE; QUETIAPINE; RISPERIDONE; VENLAFAXINE;

ACCURACY; ANALYTIC METHOD; ARTICLE; CHEMICAL PROCEDURES; CONTROLLED STUDY; DIODE ARRAY DETECTION; DRUG BLOOD LEVEL; DRUG ISOLATION; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; PH; POLYPHARMACY; PRIORITY JOURNAL; PRODUCT RECOVERY; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; SEPARATION TECHNIQUE; TOXICOKINETICS;

ANTIPSYCHOTIC AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; MOLECULAR STRUCTURE; REPRODUCIBILITY OF RESULTS; RISPERIDONE; TOXICOLOGY;

EID: 15944387339     PISSN: 16159306     EISSN: None     Source Type: Journal    
DOI: 10.1002/jssc.200401939     Document Type: Article

References (23)

1. S.L. McElroy, P.E. Keck Jr., Biol. Psychiat. 2000 48, 539-557.
2. M. Tohen, C.A. Zarate Jr., J. Clin. Psychiat. 1998 59, 38-49.
3. M.A. Raggi, Curr. Med. Chem. 2002, 9, 1397-1409.
4. A.A.H.P. Megens, F.H.L. Awouters, A. Schotte, T.F. Meert, C. Dugovic, C.J.E. Niemegeers, J.E. Leysen, Psychopharmacol. 1994 114, 9-23.
5. A. Schotte, P.F.M. Janssen, W. Gommeren, W.H.M.L. Luyten, P. Van Gompel, A.S. Lesage, K. De Loore, J.E. Leysen, Psychopharmacol. 1996, 124, 57-73.
6. S.R. Marder, R.C. Meibach, Am. J. Psychiatry 1994 151, 825-835.
7. M.B. Knable, A. Heinz, T. Raedler, D.R. Weinberger, Psychiat. Res. 1997, 75, 91-101.
8. S. Brunelleschi, P. Zeppegno, F. Risso, C.I. Cattaneo, E. Torre, Pharmacol. Res. 2003, 48, 405-409.
9. G. Chouinard, B. Jones, G. Remington, D. Bloom, D. Addington, W. MacEwan, A. Labelle, L. Beauclair, W. Arnott, J. Clin. Psychopharmacol. 1993, 13, 25-40.
10. G. Bondolfi, H. Dufour, M. Patris, J.P. May, U. Billeter, C.B. Eap, P. Baumann, Am. J. Psychiat. 1998, 155, 499-504.
11. M.A. Raggi, R. Mandrioli, V. Pucci, C. Sabbioni, Curr. Med. Chem. - Online 2004, 1, 299-316.
12. G. Mannens, M.L. Huang, W. Meuldermans, J. Hendrickx, R. Woestenborghs, J. Heykants, Drug Metab. Dispos. 1993, 21 1134-1141.
13. E. Spina, A. Avenoso, G. Facciolà, M. Salemi, M.G. Scordo, M. Ancione, A.G. Madia, E. Perucca, Psychopharmacology 2001, 153, 238-243.
14. M.A. Raggi, R. Mandrioli, C. Sabbioni, V. Pucci, Curr. Med. Chem. 2004, 11, 279-296.
15. A.A. Acri, F.M. Henretig, Am. J. Emerg. Med. 1998 16, 498-501.
16. T.A. Cheslik, J. Erramouspe, Ann. Pharmacother. 1996 30, 360-363.
17. A.C. Springfield, E. Bodiford, J. Anal. Toxicol. 1996, 20, 202-203.
18. K. Titier, S. Bouchet, F. Pehourcq, N. Moore, M. Molimard, J. Chromatogr. B 2003, 788, 179-185.
19. K. Titier, E. Deridet, E. Cardone, A. Abouelfath, N. Moore, J. Chromatogr. B 2002, 772, 373-378.
20. H.M. Hill, Chromatographia 2000, 52, 65-72.
21. United States Pharmacopeia 24th Edition, United States Pharmacopeial Convention, Rockville (MID), 2000, pp. 2150-2151.
22. A. Avenoso, G. Facciolà, M. Salemi, E. Spina, J. Chromatogr. B 2000, 746, 173-181.
23. O.V. Olesen, R.W. Licht, E. Thomsen, T. Bruun, J.E. Viftrup, K. Linnet, Ther. Drug Monit. 1998, 20, 380-384.